Inventor · disambiguated record
William Farnaby
Also filed as: FARNABY WILLIAM · FARNABY WILLIAM JOHN
23 granted patents·5 pending applications·77 citations·filing 2012–2025
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO17TAKEDA PHARMACEUTICAL4FARNABY WILLIAM3BOEHRINGER INGELHEIM INTL GMBH CORP1COCKCROFT XIAO LING FAN1
Top patents by PatentIndex Score
28 records- 0193US8648079B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2012·Granted Feb 11, 2014·13 cites·3 claims
- 0291US9440990B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Sep 13, 2016·7 cites·8 claims
- 0391US8871766B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 28, 2014·8 cites·3 claims
- 0491US8865717B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 21, 2014·8 cites·3 claims
- 0590US9193709B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Nov 24, 2015·8 cites·18 claims
- 0687US11174272B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·1 cites·16 claims
- 0786US9586930B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 7, 2017·3 cites·12 claims
- 0884US11129828B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 0981US10550129B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Feb 4, 2020·1 cites·8 claims
- 1081US10273245B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·1 cites·11 claims
- 1180US9931340B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACUETICAL COMPANY LTD·Filed 2016·Granted Apr 3, 2018·4 cites·10 claims
- 1280US9290456B2Pyridazinone compounds and their use as DAAO inhibitorsFARNABY WILLIAM·Filed 2012·Granted Mar 22, 2016·4 cites·22 claims
- 1379US10144743B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 4, 2018·1 cites·11 claims
- 1479US9180122B25- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and painFARNABY WILLIAM·Filed 2012·Granted Nov 10, 2015·6 cites·28 claims
- 1578US12186313B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jan 7, 2025·0 cites·10 claims
- 1678US9598398B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Mar 21, 2017·4 cites·14 claims
- 1777US10463663B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 5, 2019·1 cites·16 claims
- 1874US10717748B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 21, 2020·0 cites·15 claims
- 1973US9464060B2CompoundsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 11, 2016·3 cites·25 claims
- 2068US9750748B2Pyridazinones as DAAO enzyme inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·1 cites·18 claims
- 2167US10100018B2Amide derivatives as lysophosphatidic acid receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 16, 2018·1 cites·12 claims
- 2261US10085986B2Pyrimidinone compounds and their useCOCKCROFT XIAO LING FAN·Filed 2012·Granted Oct 2, 2018·1 cites·12 claims
- 2357US2013052281A1Novel compoundsFARNABY WILLIAM·Filed 2012·Application pending·0 cites
- 2452US2025145608A1Kras degrading compounds comprising annulated 2-amino-3-cyano thiophenesBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 2550US2019010129A1Amide derivatives as lysophosphatidic acid receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Application pending·0 cites
- 2646US2025354195A1Method of screeningUNIV DUNDEE·Filed 2025·Application pending·0 cites
- 2731US10059713B23-substituted 2-amino-indole derivativesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 28, 2018·0 cites·22 claims
- 2831US2017369492A11,3-substituted 2-amino-indole derivatives and analogues useful in the treatment or prevention of diabetes mellitus, obesity, and inflammatory bowel diseaseTAKEDA PHARMACEUTICALS CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Farnaby files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →